sufentanil + hydromorphone

Sufentanil + hydromorphone is a combination of two potent opioid analgesics used for the management of severe pain, typically in settings such as postoperative care or when other pain medications are inadequate. Both drugs act primarily as agonists at the mu-opioid receptor in the central nervous system, leading to analgesia and sedation. Sufentanil is known for its high potency (approximately 5–10 times more potent than fentanyl) and rapid onset, making it suitable for anesthesia induction and acute pain control[2][4][9]. Hydromorphone is also a strong opioid used for moderate-to-severe acute and chronic pain; it works by interrupting pain signaling between nerves in the brain and body[6][7]. The combination may be considered in patient-controlled analgesia (PCA) protocols to optimize efficacy while potentially balancing side effect profiles. There is evidence from comparative studies that both agents are effective, with some differences in adverse event rates and efficacy depending on timing postoperatively[1][3].